Literature DB >> 17217336

Max is acetylated by p300 at several nuclear localization residues.

Francesco Faiola1, Yi-Ting Wu, Songqin Pan, Kangling Zhang, Anthony Farina, Ernest Martinez.   

Abstract

Max is a ubiquitous transcription factor with a bHLHZip [basic HLH (helix-loop-helix) leucine zipper] DNA-binding/dimerization domain and the central component of the Myc/Max/Mad transcription factor network that controls cell growth, proliferation, differentiation and apoptotic cell death in metazoans. Max is the obligatory DNA-binding and dimerization partner for all the bHLHZip regulators of the Myc/Max/Mad network, including the Myc family of oncoproteins and the Mad family of Myc antagonists, which recognize E-box DNA elements in the regulatory regions of target genes. Max lacks a transcription regulatory domain and is the only member of the network that efficiently homodimerizes. Binding of Max homodimers to E-box elements suppresses the transcription regulatory functions of its network partners and of other non-network E-box-binding regulators. In contrast with its highly regulated partners, Max is a constitutively expressed and phosphorylated protein. Phosphorylation is, however, the only Max post-translational modification identified so far. In the present study, we have analysed Max posttranslational modifications by MS. We have found that Max is acetylated at several lysine residues (Lys-57, Lys-144 and Lys-145) in mammalian cells. Max acetylation is stimulated by inhibitors of histone deacetylases and by overexpression of the p300 co-activator/HAT (histone acetyltransferase). The p300 HAT also directly acetylates Max in vitro at these three residues. Interestingly, the three Max residues acetylated in vivo and in vitro by p300 are important for Max nuclear localization and Max-mediated suppression of Myc transactivation. These results uncover novel post-translational modifications of Max and suggest the potential regulation of specific Max complexes by p300 and reversible acetylation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17217336      PMCID: PMC1876387          DOI: 10.1042/BJ20061593

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  59 in total

1.  Coexamination of site-specific transcription factor binding and promoter activity in living cells.

Authors:  K E Boyd; P J Farnham
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc.

Authors:  S B McMahon; M A Wood; M D Cole
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max.

Authors:  I Västrik; T P Mäkelä; P J Koskinen; K Alitalo
Journal:  Oncogene       Date:  1995-08-03       Impact factor: 9.867

4.  Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain.

Authors:  A R Ferré-D'Amaré; G C Prendergast; E B Ziff; S K Burley
Journal:  Nature       Date:  1993-05-06       Impact factor: 49.962

5.  An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3.

Authors:  N Schreiber-Agus; L Chin; K Chen; R Torres; G Rao; P Guida; A I Skoultchi; R A DePinho
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

6.  Max activity is affected by phosphorylation at two NH2-terminal sites.

Authors:  P J Koskinen; I Västrik; T P Mäkelä; R N Eisenman; K Alitalo
Journal:  Cell Growth Differ       Date:  1994-03

7.  Antiproliferative properties of the USF family of helix-loop-helix transcription factors.

Authors:  X Luo; M Sawadogo
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

8.  Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3.

Authors:  D E Ayer; Q A Lawrence; R N Eisenman
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

9.  Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers.

Authors:  K Bousset; M Henriksson; J M Lüscher-Firzlaff; D W Litchfield; B Lüscher
Journal:  Oncogene       Date:  1993-12       Impact factor: 9.867

10.  Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.

Authors:  P J Hurlin; C Quéva; P J Koskinen; E Steingrímsson; D E Ayer; N G Copeland; N A Jenkins; R N Eisenman
Journal:  EMBO J       Date:  1995-11-15       Impact factor: 11.598

View more
  10 in total

1.  The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention.

Authors:  Andrea R Daniel; Angela L Gaviglio; Lauren M Czaplicki; Christopher J Hillard; Daniel Housa; Carol A Lange
Journal:  Mol Endocrinol       Date:  2010-09-22

Review 2.  Small-molecule inhibitors of the Myc oncoprotein.

Authors:  Steven Fletcher; Edward V Prochownik
Journal:  Biochim Biophys Acta       Date:  2014-03-19

3.  Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.

Authors:  Megan M Romeo; Bookyung Ko; Janice Kim; Rebecca Brady; Hayley C Heatley; Jeffrey He; Carolyn K Harrod; Braden Barnett; Lee Ratner; Michael D Lairmore; Ernest Martinez; Bernhard Lüscher; Craig N Robson; Marie Henriksson; Robert Harrod
Journal:  Virology       Date:  2015-01-05       Impact factor: 3.616

4.  STAT1 signaling is not regulated by a phosphorylation-acetylation switch.

Authors:  Filipa Antunes; Andreas Marg; Uwe Vinkemeier
Journal:  Mol Cell Biol       Date:  2011-05-16       Impact factor: 4.272

5.  MYC interacts with the human STAGA coactivator complex via multivalent contacts with the GCN5 and TRRAP subunits.

Authors:  Na Zhang; Wataru Ichikawa; Francesco Faiola; Szu-Ying Lo; Xiaohui Liu; Ernest Martinez
Journal:  Biochim Biophys Acta       Date:  2014-04-03

Review 6.  The many lives of KATs - detectors, integrators and modulators of the cellular environment.

Authors:  Bilal N Sheikh; Asifa Akhtar
Journal:  Nat Rev Genet       Date:  2019-01       Impact factor: 53.242

7.  The B-WICH chromatin-remodelling complex regulates RNA polymerase III transcription by promoting Max-dependent c-Myc binding.

Authors:  Fatemeh Sadeghifar; Stefanie Böhm; Anna Vintermist; Ann-Kristin Östlund Farrants
Journal:  Nucleic Acids Res       Date:  2015-04-16       Impact factor: 16.971

8.  Identification of acetylation-dependent regulatory mechanisms that govern the oncogenic functions of Skp2.

Authors:  Zhiwei Wang; Hiroyuki Inuzuka; Jiateng Zhong; Pengda Liu; Fazlul H Sarkar; Yi Sun; Wenyi Wei
Journal:  Oncotarget       Date:  2012-11

9.  Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation.

Authors:  Yiyu Zhang; Aleksandra Dakic; Renxiang Chen; Yuhai Dai; Richard Schlegel; Xuefeng Liu
Journal:  Oncotarget       Date:  2017-10-25

Review 10.  Emerging roles of histone modifications and HDACs in RNA splicing.

Authors:  Raneen Rahhal; Edward Seto
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.